litlas
Log inCreate account

Robert H. Jones

Active 1977–2025

108
Papers
31,541
Citations
83
h-index
104
i10-index

Citations

Citations per year for Robert H. Jones1979: 6 citations1980: 12 citations1981: 16 citations1982: 11 citations1983: 25 citations1984: 15 citations1985: 26 citations1986: 19 citations1987: 20 citations1988: 24 citations1989: 15 citations1990: 28 citations1991: 20 citations1992: 17 citations1993: 22 citations1994: 14 citations1995: 38 citations1996: 41 citations1997: 36 citations1998: 42 citations1999: 61 citations2000: 78 citations2001: 107 citations2002: 156 citations2003: 196 citations2004: 211 citations2005: 246 citations2006: 301 citations2007: 265 citations2008: 213 citations2009: 209 citations2010: 212 citations2011: 228 citations2012: 218 citations2013: 172 citations2014: 218 citations2015: 121 citations2016: 117 citations2017: 75 citations2018: 103 citations2019: 379 citations2020: 369 citations2021: 396 citations2022: 302 citations2023: 233 citations2024: 624 citations2025: 417 citations2026: 10 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,644 citing papers, 30.8% of this breakdownUnited Kingdom: 683 citing papers, 8% of this breakdownChina: 640 citing papers, 7.4% of this breakdownCanada: 432 citing papers, 5% of this breakdownGermany: 418 citing papers, 4.9% of this breakdownItaly: 383 citing papers, 4.5% of this breakdownFrance: 265 citing papers, 3.1% of this breakdownNetherlands: 263 citing papers, 3.1% of this breakdownAustralia: 252 citing papers, 2.9% of this breakdownSpain: 182 citing papers, 2.1% of this breakdownJapan: 177 citing papers, 2.1% of this breakdownSweden: 161 citing papers, 1.9% of this breakdown
0%30.8%Other 24.2%

Institutions

Fields

  • Medicine79.7%
  • Biochemistry, Genetics and Molecular Biology10.4%
  • Health Professions1.6%
  • Immunology and Microbiology1.2%
  • Engineering1.1%
  • Neuroscience1%
  • Other5%

Topics

  • Cardiac Imaging and Diagnostics5.4%
  • Acute Myocardial Infarction Research5.1%
  • Coronary Interventions and Diagnostics4.1%
  • Cardiac and Coronary Surgery Techniques3.7%
  • Cardiac, Anesthesia and Surgical Outcomes2.6%
  • Cardiovascular Function and Risk Factors2.4%
  • Other76.7%

Coauthors

All papers

Open in search
  1. PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

    Authors: Antonino Glaviano, Aaron Song Chuan Foo, Hiu Yan Lam, Kenneth Chun-Yong Yap, William Jacot, Robert H. Jones, Huiyan Eng, Madhumathy G Nair, Pooyan Makvandi, Birgit Geoerger, Matthew H. Kulke, Richard D. Baird, Jyothi S. Prabhu, Daniela Carbone, Camilla Pecoraro, Daniel Boon Loong Teh, Gautam Sethi, Vincenzo Cavalieri, Kevin Lin, Nathalie Javidi‐Sharifi, Eneda Toska, Matthew S. Davids, Jennifer R. Brown, Patrizia Diana, Justin Stebbing, David A. Fruman, Alan Prem Kumar - Molecular Cancer 2023 cited by 1,908

  2. Coronary-Artery Bypass Surgery in Patients with Ischemic Cardiomyopathy

    Authors: Eric J. Velazquez, Kerry L. Lee, Robert H. Jones, Hussein R. Al‐Khalidi, James A. Hill, Julio A. Panza, Robert E. Michler, Robert O. Bonow, Torsten Doenst, Mark C. Petrie, Jae K. Oh, Lilin She, Vanessa Moore, Patrice Desvigne‐Nickens, George Sopko, Jean L. Rouleau - New England Journal of Medicine 2016 cited by 1,043

  3. Tisotumab vedotin in patients with advanced or metastatic solid tumours (InnovaTV 201): a first-in-human, multicentre, phase 1–2 trial

    Authors: Johann S. de Bono, Nicole Concin, David S. Hong, Fiona Thistlethwaite, Jean-Pascal Machiels, Hendrik‐Tobias Arkenau, Ruth Plummer, Robert H. Jones, Dorte Nielsen, Kristian Windfeld, Srinivas Ghatta, Brian M. Slomovitz, James Spicer, Jeffrey Yachnin, Joo Ern Ang, Paul Morten Mau-Sørensen, Martin Förster, Dearbhaile Catherine Collins, Emma Dean, Reshma Rangwala, Ulrik Lassen - The Lancet Oncology 2019 cited by 230

  4. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION): overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial

    Authors: Sacha J. Howell, Angela Casbard, Margherita Carucci, Kate Ingarfield, Rachel Butler, Siân Morgan, Magdalena Meissner, C. Bale, Pavel Bezecny, Sarah Moon, Chris Twelves, Ramachandran Venkitaraman, Simon Waters, Elza C. de Bruin, Gaia Schiavon, Andrew Foxley, Robert H. Jones - The Lancet Oncology 2022 cited by 143

  5. Coronary Artery Bypass Surgery in Patients with Left Ventricular Dysfunction

    Authors: Eric J. Velazquez, Kerry L. Lee, Marek Deja, Anil Jain, George Sopko, А. В. Марченко, Imtiaz S. Ali, Gerald Pohost, Siniša Gradinac, William T. Abraham, Michael Yii, Dorairaj Prabhakaran, Hanna Szwed, Paolo Ferrazzi, Mark C. Petrie, Christopher M. O’Connor, Pradit Panchavinnin, Lilin She, Robert O. Bonow, Gena Roush Rankin, Robert H. Jones, Jean‐Lucien Rouleau - New England Journal of Medicine 2011 cited by 1,293

  6. Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive breast cancer (FAKTION): a multicentre, randomised, controlled, phase 2 trial

    Authors: Robert H. Jones, Angela Casbard, Margherita Carucci, Catrin Cox, Rachel Butler, Fouad Alchami, Tracie‐Ann Madden, C. Bale, Pavel Bezecny, Johnathan Joffe, Sarah Moon, Chris Twelves, Ramachandran Venkitaraman, Simon Waters, Andrew Foxley, Sacha J. Howell - The Lancet Oncology 2020 cited by 227

  7. Olaparib combined with abiraterone in patients with metastatic castration-resistant prostate cancer: a randomised, double-blind, placebo-controlled, phase 2 trial

    Authors: Noel W. Clarke, Paweł Wiechno, B. Yа. Alekseev, Núria Sala, Robert H. Jones, Ivo Kocák, Vincenzo Emanuele Chiurì, Jacek Jassem, Aude Fléchon, Charles H. Redfern, Carsten Goessl, Joseph E. Burgents, Robert Kozarski, Darren Hodgson, Maria Learoyd, Fred Saad - The Lancet Oncology 2018 cited by 409

  8. Longitudinal Assessment of Neurocognitive Function after Coronary-Artery Bypass Surgery

    Authors: Mark F. Newman, Jerry Kirchner, Barbara Phillips‐Bute, Vincent Gaver, Hilary P. Grocott, Robert H. Jones, Daniel B. Mark, J. G. Rêves, James A. Blumenthal - New England Journal of Medicine 2001 cited by 1,970

  9. Tisotumab Vedotin in Previously Treated Recurrent or Metastatic Cervical Cancer

    Authors: David S. Hong, Nicole Concin, Ignace Vergote, Johann S. de Bono, Brian M. Slomovitz, Yvette Drew, Hendrik‐Tobias Arkenau, Jean-Pascal Machiels, James Spicer, Robert H. Jones, Martin Förster, Nathalie Cornez, Christine Gennigens, Melissa L. Johnson, Fiona Thistlethwaite, Reshma Rangwala, Srinivas Ghatta, Kristian Windfeld, Jeffrey R. Harris, Ulrik Lassen, Robert L. Coleman - Clinical Cancer Research 2019 cited by 126

  10. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction

    Authors: Robert O. Bonow, Gerald Maurer, Kerry L. Lee, Thomas A. Holly, Philip F. Binkley, Patrice Desvigne‐Nickens, Jarosław Dróżdż, Pedro Sílvio Farsky, Arthur M. Feldman, Torsten Doenst, Robert E. Michler, Daniel S. Berman, José Carlos Nicolau, Patricia A. Pellikka, Krzysztof Wróbel, Nasri Alotti, Federico M. Asch, Liliana E. Favaloro, Lilin She, Eric J. Velazquez, Robert H. Jones, Julio A. Panza - New England Journal of Medicine 2011 cited by 879

  11. Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer

    Authors: Martin Scurr, Tom Pembroke, Anja Bloom, David C. S. Roberts, Amanda Thomson, Kathryn Smart, Hayley Bridgeman, Richard Adams, A. Brewster, Robert H. Jones, Sarah Gwynne, Daniel G. Blount, Richard Harrop, Robert K. Hills, Awen Gallimore, Andrew Godkin - Clinical Cancer Research 2017 cited by 164

  12. Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatment

    Authors: Antonino Glaviano, Seth A. Wander, Richard D. Baird, Kenneth Chun-Yong Yap, Hiu Yan Lam, Masakazu Toi, Daniela Carbone, Birgit Geoerger, Violeta Serra, Robert H. Jones, Joanne Ngeow, Eneda Toska, Justin Stebbing, Karen Crasta, Richard S. Finn, Patrizia Diana, Karla Vuina, Robertus A.M. de Bruin, Uttam Surana, Aditya Bardia, Alan Prem Kumar - Drug Resistance Updates 2024 cited by 58

  13. A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer

    Authors: Robert H. Jones, Ruth Plummer, Víctor Moreno, Louise Carter, Desamparados Roda, Elena Garralda, Rebecca Kristeleit, Debashis Sarker, Hendrik‐Tobias Arkenau, Patricia Roxburgh, Harriet S. Walter, Sarah P. Blagden, Alan Anthoney, Barbara Klencke, Mark Kowalski, Udai Banerji - Clinical Cancer Research 2022 cited by 41

  14. A Phase 1/2 trial of SRA737 (a Chk1 inhibitor) administered orally in patients with advanced cancer

    Authors: Rebecca Kristeleit, Ruth Plummer, Robert H. Jones, Louise Carter, Sarah P. Blagden, Debashis Sarker, Hendrik‐Tobias Arkenau, T.R. Jeffry Evans, Sarah Danson, Stefan N. Symeonides, Gareth J. Veal, Barbara Klencke, Mark Kowalski, Udai Banerji - British Journal of Cancer 2023 cited by 36

  15. Depression as a risk factor for mortality after coronary artery bypass surgery

    Authors: James A. Blumenthal, Heather S. Lett, Michael A. Babyak, William D. White, Peter K. Smith, Daniel B. Mark, Robert H. Jones, Joseph P. Mathew, Mark F. Newman - The Lancet 2003 cited by 661

  16. Phase I/II study of H3B-6545, a novel selective estrogen receptor covalent antagonist (SERCA), in estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer.

    Authors: Erika Hamilton, Judy S. Wang, Timothy Pluard, Stephen Johnston, Aki Morikawa, Elizabeth Claire Dees, Robert H. Jones, Barbara Haley, Anne Armstrong, Adam L. Cohen, Pamela N. Münster, Gail Lynn Shaw Wright, Fadi Kayali, Manav Korpal, Jianjun Xiao, Jenny Long, Benoit Destenaves, Lei Gao, Antonio Gualberto, Dejan Juric - Journal of Clinical Oncology 2021 cited by 37

  17. Inhibition of WEE1 Is Effective in TP53- and RAS-Mutant Metastatic Colorectal Cancer: A Randomized Trial (FOCUS4-C) Comparing Adavosertib (AZD1775) With Active Monitoring

    Authors: Jenny F. Seligmann, David J. Fisher, Louise Brown, Richard Adams, Janet Graham, Philip Quirke, Susan D. Richman, Rachel Butler, Enric Domingo, Andrew Blake, Emma Yates, Michael Braun, Fiona Collinson, Robert H. Jones, Ewan Brown, Emma De Winton, Timothy C. Humphrey, Mahesh Parmar, Richard Kaplan, Richard H. Wilson, Michel Seymour, Tim Maughan - 2021 cited by 49

  18. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial

    Authors: Fred Saad, Antoine Thiery-Vuillemin, Paweł Wiechno, B. Yа. Alekseev, Núria Sala, Robert H. Jones, Ivo Kocák, Vincenzo Emanuele Chiurì, Jacek Jassem, Aude Fléchon, Charles H. Redfern, Jinyu Kang, Joseph E. Burgents, Christopher Gresty, Arnold Degboe, Noel W. Clarke - The Lancet Oncology 2022 cited by 30

  19. Targeted Inhibition of CYP11A1 in Castration-Resistant Prostate Cancer

    Authors: Karim Fizazi, Alice Bernard‐Tessier, Guilhem Roubaud, Tapio Utriainen, Philippe Barthélémy, Aude Fléchon, Johannes Van Der Voet, Gwénaëlle Gravis, Raffaele Ratta, Robert H. Jones, Omi Parikh, Minna Tanner, Emmanuel S. Antonarakis, Capucine Baldini, Niamh Peters, Chris Garratt, Tarja Ikonen, Pasi Pohjanjousi, Heikki Joensuu, Natalie Cook - NEJM Evidence 2023 cited by 24

  20. Coronary Bypass Surgery with or without Surgical Ventricular Reconstruction

    Authors: Robert H. Jones, Eric J. Velazquez, Robert E. Michler, George Sopko, Jae K. Oh, Christopher M. O’Connor, James A. Hill, Lorenzo Menicanti, Zygmunt Sadowski, Patrice Desvigne‐Nickens, Jean L. Rouleau, Kerry L. Lee - New England Journal of Medicine 2009 cited by 724

  21. Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury

    Authors: Karla B Neves, Francisco J. Rios, Robert H. Jones, T.R. Jeffry Evans, Augusto C. Montezano, Rhian M. Touyz - Cardiovascular Research 2019 cited by 45

  22. ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations

    Authors: Eugene Braunwald, Elliott M. Antman, John W. Beasley, Robert M. Califf, Melvin D. Cheitlin, Judith S. Hochman, Robert H. Jones, Dean J. Kereiakes, Joel Kupersmith, Thomas N. Levin, Carl J. Pepine, John W. Schaeffer, Earl E. Smith, David E. Steward, Pierre Théroux, Raymond J. Gibbons, Joseph S. Alpert, Kim A. Eagle, David P. Faxon, Valentı́n Fuster, Timothy J. Gardner, Gabriel Gregoratos, Richard O. Russell, Sidney C. Smith - Circulation 2000 cited by 4,515

  23. Influence of Mitral Regurgitation Repair on Survival in the Surgical Treatment for Ischemic Heart Failure Trial

    Authors: Marek Deja, Paul Grayburn, Benjamin Sun, Vivek Rao, Lilin She, Michał Krejca, Anil Jain, Yeow Leng Chua, Richard C. Daly, Michele Senni, Krzysztof Mokrzycki, Lorenzo Menicanti, Jae K. Oh, Robert E. Michler, Krzysztof Wróbel, André Lamy, Eric J. Velazquez, Kerry L. Lee, Robert H. Jones - Circulation 2012 cited by 251

  24. Association of Neurocognitive Function and Quality of Life 1 Year After Coronary Artery Bypass Graft (CABG) Surgery

    Authors: Barbara Phillips‐Bute, Joseph P. Mathew, James A. Blumenthal, Hilary P. Grocott, Daniel T. Laskowitz, Robert H. Jones, Daniel B. Mark, Mark F. Newman - Psychosomatic Medicine 2006 cited by 220